0 NASDAQ Companies - August 10, 2020Lightbridge Provides Business Update and Announces Second Quarter of 2020 Earnings ResultsRESTON, Va., Aug. 10, 2020 (GLOBE NEWSWIRE) — Lightbridge Corporation (NASDAQ: LTBR), an advanced nuclear fuel technology company, today announced […]Read More
0 NASDAQ Companies - August 10, 2020Marrone Bio Innovations, Inc. Reports Second Quarter and First Half 2020 Financial ResultsSecond-Quarter Revenue Increased 74% to Record $12.2 MillionRecord Gross Margins of 60.6% Mark Seventh Consecutive Quarter of 50%+ MarginsDAVIS, Calif., […]Read More
0 NASDAQ Companies - August 10, 2020Data from EXPLORER-HCM Study Selected for Virtual Late-Breaker Presentation at the European Society of Cardiology Congress 2020BRISBANE, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced that the company will present 38-week […]Read More
0 NASDAQ Companies - August 10, 2020Homology Medicines Reports Second Quarter 2020 Financial Results and Provides Business UpdateThree Cohorts Enrolled in Phase 1/2 pheNIX Gene Therapy Trial for PKUProgressed Into Later Stages of IND-Enabling Studies for MLD […]Read More
0 NASDAQ Companies - August 10, 2020Reed’s, Inc. Announces Second Quarter 2020 Financial ResultsNet sales increased 14%Gross Margin increased 350 basis pointsMaintains fiscal 2020 outlookNORWALK, Conn., Aug. 10, 2020 (GLOBE NEWSWIRE) — Reed’s […]Read More
0 NYSE Companies - August 10, 2020Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights– ENHANCE-IT study of MAT9001 against Vascepa® expected to be fully enrolled in August 2020; topline data anticipated Q1 2021 […]Read More
0 NYSE Companies - August 10, 2020CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business UpdateBERKELEY HEIGHTS, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) — CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing […]Read More
0 NASDAQ Companies - August 10, 2020Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for wet AMD, Reports Recent Business Progress and Second Quarter 2020 Financial Results— Continued robust treatment response from both high and low doses —— Long-term durability beyond 15 months from single IVT […]Read More
0 NASDAQ Companies - August 10, 2020Harrow Health Publishes Second Quarter 2020 Letter to StockholdersNASHVILLE, Tenn., Aug. 10, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter […]Read More
0 NASDAQ Companies - August 10, 2020Atlas Technical Consultants Announces Agreement to Acquire Colorado Based WesTestAUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading […]Read More